FDA Rx Risk Assessment Guidance May Detail Lab Test Parameters
Executive Summary
FDA's risk assessment working group is considering developing specific recommendations on which lab test results could signal safety problems for drugs under review
You may also be interested in...
FDA Risk “Concept Papers” Expected In March; April Workshop Set
FDA hopes to release three "concept papers" on risk assessment and risk management March 10 as the first step in developing risk guidances mandated under the Prescription Drug User Fee Act reauthorization
FDA Risk “Concept Papers” Expected In March; April Workshop Set
FDA hopes to release three "concept papers" on risk assessment and risk management March 10 as the first step in developing risk guidances mandated under the Prescription Drug User Fee Act reauthorization
Rx Risk Management Guidances: FDA To Seek Input Through Public Meetings
FDA will hold a series of public meetings on risk assessment, risk management and pharmacovigilance over the next 12 months in preparation for drafting guidances on those topics